FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2405990018> ?p ?o ?g. }

• W2405990018 endingPage "7" @default.
• W2405990018 startingPage "161" @default.
• W2405990018 abstract "This study investigated the frequency of angiotensin-converting enzyme (ACE) genotypes, concentrations of total cholesterol (T-C), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), lipoprotein Lp (a), Established Risk Factor (ERF) ratio (total cholesterol/HDL-C), apolipoproteins A-I, A-II, apoBand apoE in 134 menopausal women aged 49.62 +/- 4.83 on oral hormone replacement therapy (HRT) (2 mg 17 beta estradiol plus 1 mg norethisterone acetate/day), during (mean +/- SD) 15.77 +/- 9.94 months. ACE genotypes of 134 menopausal women showed DD genotype in 48 (36%), ID genotype in 59 (44%), and II genotype in 27 (20%) women, with the mean body mass index (BMI) (kg/m2) of 26.34 +/- 4.02, systolic blood pressure (mm Hg) of 145.71 +/- 23.32, diastolic blood pressure of 95.28 +/- 12.88, pulse rate of 77.76 +/- 13.81, positive family history of myocardial infarction (MI) (23%) and stroke (22%); 26% were smokers and 6% consumed alcohol regularly. The mean levels of TC (mmol/l) were 5.72 +/- 1.25, TG (mmol/L) 1.63 +/- 0.82, HDL-C (mmol/L) 1.15 +/- 0.29, LDL-C (mmol/L) 3.98 +/- 1.31, lipoprotein Lp(a) (g/L) 0.16 +/- 0.24, ERF ratio 5.35 +/- 1.90, apolipoproteins (g/L): A-I 1.83 +/- 0.39, A-II 0.57 +/- 0.12, apoB 0.92 +/- 0.31, and apoE 0.08 +/- 0.04. The highest mean levels of T-C 5.89 +/- 1.40, TG 1.67 +/- 0.96, LDL-C 4.15 +/- 1.60, lipoprotein Lp(a) 0.19 +/- 0.25) apoB 0.95 +/- 0.32 and ERF ratio 5.46 +/- 2.24 were found in ID genotype, while in DD genotype HDL-C 1.11 +/- 0.28 and apo A-I 1.78 +/- 0.34 were lowest. In II genotype, the levels of apo A-II 0.56 +/- 0.11 were lowest and of apoE 0.09 +/- 0.05 highest. According to DD, ID and II genotypes and lipid, lipoprotein Lp(a), ERF ratio and apolipoprotein concentrations, there were no statistically significant differences between groups. ERF ratio in DD genotype showed a positive correlation with TG (r = 0.59) and LDL-C (r = 0.57), a slight positive correlation with apoB (r = 0.40), and a strong negative correlation with HDL-C (r = -0.73). ERF in ID genotype showed a strong negative correlation with HDL-C (r = -0.73), strong positive correlation with TG (r = 0.70), and T-C (r = 0.58), and slight positive correlation with LDL-C (r = 0.36) and alcohol abuse (r = 0.34). In II genotype, ERF ratio showed a strong positive correlation with LDL-C (r = 0.73), T-C (r = 0.70) and apoE (r = 0.58), slight positive correlation with apoB (r = 0.46) and TG (r = 0.36), and negative correlation with HDL-C (r = -0.54). Matrix correlation of DD genotypes showed the highest positive correlation between T-C and LDL-C (r = 0.91) and apoE (r = 0.45), and negative correlation between HDL-C and ERF ratio (r = 77), and LDL-C and ERF ratio (r = 0.55). In ID genotype, T-C showed a strong positive correlation between LDL-C (r = 0.75) and ERF ratio (r = 0.63), TG and ERF ratio (r = 0.73), and negative with HDL-C (r = 0.53). In genotype II, T-C showed a strong positive correlation between LDL-C (r = 0.96), ERF ratio (r = 0.71), apoB (r = 0.66) and apoE (r = 0.46). LDL-C correlated positively with ERF ratio (r = 0.72), apoB (r = 0.61) and apoE (r = 0.48). These findings indicated the frequency of ACE genotypes to differ within the group of menopausal women. Analysis of ACE genotypes showed ID genotype to be most common among menopausal women. This result indicated their intermediate risk of coronary heart disease (CHD) and myocardial infarction (MI). It has been well established that an increased risk of MI is associated with high frequency of DD genotype, and a low risk with high frequencies of II genotype. In addition to ACE polymorphism analysis, assessment of lipid, apolipoprotein, and lipoprotein Lp(a) concentrations, and of ERF ratio provides further important parameters for better understanding of the risk factors for CDH in women. In the present study, assessment of the genetic, metabolic and environmental markers pointed to an intermediate risk of CHD in menopausal women on HRT, although the mechanism underlying the disease is not clear and well understood yet." @default.
• W2405990018 created "2016-06-24" @default.
• W2405990018 creator A5003534549 @default.
• W2405990018 creator A5031579075 @default.
• W2405990018 creator A5046862096 @default.
• W2405990018 date "2001-01-01" @default.
• W2405990018 modified "2023-09-23" @default.
• W2405990018 title "Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy." @default.
• W2405990018 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12398019" @default.
• W2405990018 hasPublicationYear "2001" @default.
• W2405990018 type Work @default.
• W2405990018 sameAs 2405990018 @default.
• W2405990018 citedByCount "2" @default.
• W2405990018 crossrefType "journal-article" @default.
• W2405990018 hasAuthorship W2405990018A5003534549 @default.
• W2405990018 hasAuthorship W2405990018A5031579075 @default.
• W2405990018 hasAuthorship W2405990018A5046862096 @default.
• W2405990018 hasConcept C104317684 @default.
• W2405990018 hasConcept C126322002 @default.
• W2405990018 hasConcept C134018914 @default.
• W2405990018 hasConcept C135763542 @default.
• W2405990018 hasConcept C139572402 @default.
• W2405990018 hasConcept C185592680 @default.
• W2405990018 hasConcept C27016395 @default.
• W2405990018 hasConcept C2778163477 @default.
• W2405990018 hasConcept C2779279991 @default.
• W2405990018 hasConcept C2780072125 @default.
• W2405990018 hasConcept C2780159708 @default.
• W2405990018 hasConcept C2780221984 @default.
• W2405990018 hasConcept C55493867 @default.
• W2405990018 hasConcept C71924100 @default.
• W2405990018 hasConcept C84393581 @default.
• W2405990018 hasConceptScore W2405990018C104317684 @default.
• W2405990018 hasConceptScore W2405990018C126322002 @default.
• W2405990018 hasConceptScore W2405990018C134018914 @default.
• W2405990018 hasConceptScore W2405990018C135763542 @default.
• W2405990018 hasConceptScore W2405990018C139572402 @default.
• W2405990018 hasConceptScore W2405990018C185592680 @default.
• W2405990018 hasConceptScore W2405990018C27016395 @default.
• W2405990018 hasConceptScore W2405990018C2778163477 @default.
• W2405990018 hasConceptScore W2405990018C2779279991 @default.
• W2405990018 hasConceptScore W2405990018C2780072125 @default.
• W2405990018 hasConceptScore W2405990018C2780159708 @default.
• W2405990018 hasConceptScore W2405990018C2780221984 @default.
• W2405990018 hasConceptScore W2405990018C55493867 @default.
• W2405990018 hasConceptScore W2405990018C71924100 @default.
• W2405990018 hasConceptScore W2405990018C84393581 @default.
• W2405990018 hasIssue "4-5" @default.
• W2405990018 hasLocation W24059900181 @default.
• W2405990018 hasOpenAccess W2405990018 @default.
• W2405990018 hasPrimaryLocation W24059900181 @default.
• W2405990018 hasRelatedWork W1984261625 @default.
• W2405990018 hasRelatedWork W1996680438 @default.
• W2405990018 hasRelatedWork W2026528588 @default.
• W2405990018 hasRelatedWork W2036860907 @default.
• W2405990018 hasRelatedWork W2123662096 @default.
• W2405990018 hasRelatedWork W2128049273 @default.
• W2405990018 hasRelatedWork W2154280507 @default.
• W2405990018 hasRelatedWork W2157219243 @default.
• W2405990018 hasRelatedWork W2352458837 @default.
• W2405990018 hasRelatedWork W2410184831 @default.
• W2405990018 hasVolume "55" @default.
• W2405990018 isParatext "false" @default.
• W2405990018 isRetracted "false" @default.
• W2405990018 magId "2405990018" @default.
• W2405990018 workType "article" @default.